Gerhardt Attard
MD
Professor of Precision Oncology
👥Biography 个人简介
Gerhardt Attard at UCL Cancer Institute is a leading researcher in androgen receptor biology and liquid biopsy in prostate cancer. His early phase trial work on abiraterone was pivotal in demonstrating its activity, and his mechanistic studies defining AR amplification, mutation, and splice variant resistance have fundamentally advanced understanding of CYP17A1 inhibitor resistance. His work on cfDNA has opened liquid biopsy applications in prostate cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Gerhardt Attard 的研究动态
Follow Gerhardt Attard's research updates
留下邮箱，当我们发布与 Gerhardt Attard（University College London Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment